HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe

Diabetes: Study Looks at Self-Monitoring and Health Outcomes for Type 2 Clients

July 1, 2007 by HME Business

Research based on a year-long study and reported at the American Diabetes Association’s 67th Annual Scientific Sessions last June calls into question whether frequent glucose self-monitoring by type 2 diabetes patients who do not use insulin leads to better control of their sugar levels.


“No self-monitoring was compared to two different intensities of self-monitoring, and no clinically significant different reductions were seen in results on A1C tests,” reported Andrew J. Farmer, a principal investigator on the Diabetes Glycemic Education and Monitoring (DiGEM) study.


The DiGEM team wanted better answers than have so far been available to the question of whether self-monitoring actually leads to better outcomes for type 2 diabetics. While physicians and others involved in diabetes care acknowledge self-monitoring can be expensive and a hassle, they assumed that patients could best manage their sugar levels if they continuously kept track of them during the day or week.

Previous research that tested this assumption was inconclusive because subjects’ glycemic control (or lack of it) could have been explained by multiple factors, self monitoring being only one.


The research followed three groups of type 2 diabetics for a year. Members of one group didn’t self-monitor, but followed generally accepted guidelines about diet and exercise, and they checked in with their doctors every three months. The other two groups self-monitored, one more intensively than the other.


The researchers found virtually no difference among the groups in how well blood glucose was managed. “At baseline, mean A1C glycated hemoglobin, which measures how well patients control their glucose during the previous two to three months across the groups was similar at 7.5 percent. At 12 months, the results were again similar. The mean A1C difference between the control and less-intensive self monitoring group was -0.14 percent, and between the control and more-intensive self-monitoring group -0.17 percent. The differences between the three groups were not statistically significant (P=0.12).”


The researchers wrote that for self-monitoring to have been vindicated, it would have had to make a difference of at least -0.5 percent. “We powered the study to be able to see a difference that large if it existed,” said Farmer, “but we did not get it.”

Related Articles Read More >

NCPA Announces New Senior Vice President of the Office of CEO
Sara Roszak is an industry veteran who most recently served at the National Association of Chain Drug Stores.
More HCPCS Codes to Be Added to Medicare Prior Authorization Process in October
Prior authorization will be required for eight additional codes for dates of service of Oct. 28 and later.
M&A Update, Part 2: What Makes a Good Investment or Acquisition?
At the HME Business FUTURE conference, experts on mergers and acquisitions took the stage.
Frazier Healthcare Acquires MatrixCare, Appoints CEO
MatrixCare was owned by Resmed.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe